Anthe Zandvliet

Director, Integrated Drug Development

About Anthe Zandvliet

Dr. Zandvliet joined Certara as Director, Consulting Services in February 2018 with a background in clinical healthcare and pharma R&D where she provides expertise as a clinical pharmacist specializing in clinical oncology, clinical pharmacology, and pharmacometrics, with interests in high cost drugs, biologicals, immunology and oncology, and dose regimen optimization and individualization.

Prior to coming to Certara, Dr. Zandvliet was a clinical oncology pharmacist at the VU University Medical Center in Amsterdam and Principal Scientist in Clinical PK/PD at Merck where she provided support in clinical pharmacology, pharmacokinetic-pharmacodynamic modeling and simulation (PK/PD M&S), Phase 2–3 clinical development, regulatory interactions, monoclonal antibodies, and oncology.

Dr. Zandvliet received her PharmD from the University of Utrecht, PhD and certification in Clinical Pharmacology at the Netherlands Cancer Institute, and certification in Clinical Pharmacy from VU University Medical Center.